US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
Upcoming IPOs
Code
Name
Industry Offer Price Lot Size Entry Fee Offer Period
Listing Date
02167.HK TI Cloud Inc N/A 12.85-13.85 200 2,798 2022/06/21-2022/06/24 2022/06/30
02372.HK WEIli Holdings N/A 0.63-0.67 4,000 2,707 2022/06/17-2022/06/22 2022/06/30
02391.HK Tuya Inc N/A 22.80 200 4,606 2022/06/22-2022/06/27 2022/07/05
09955.HK ClouDr Group N/A 30.50 100 3,081 2022/06/23-2022/06/28 2022/07/06
02297.HK Rainmed Medical N/A 4.28-6.24 1,000 6,303 2022/06/27-2022/06/30 2022/07/08
02376.HK Lushang Life Services Co., Ltd. N/A 5.3-7.92 500 4,000 2022/06/27-2022/06/30 2022/07/08
02392.HK Xuan Wu Cloud Technology Holdings N/A 4.93-6.91 500 3,490 2022/06/24-2022/06/30 2022/07/08
2022/06/21 13:37
Recommend
129
Positive
223
Negative
63
INNOVENT BIO (01801.HK) issued a clarification statement that the new drug application for its innovative PD-1 inhibitor TYVYT had been approved. The stock skyrocketed 15% to last post at $31.1.The rest of pharmas were generally in shape. BRII-B (02137.HK) soared 8.8% to $8.9. CANSINOBIO (06185.HK) advanced 6.2% to $81.15.~AASto...
2022/06/17 15:52
Recommend
78
Positive
157
Negative
26
Pharmaceuticals outran the market today broadly, in particular JUNSHI BIO (01877.HK), which shot up 12% to $45.2. The company's VV116 industrialization project filing was approved by the management committee of the Zhangjiang High-Tech Park.INNOVENT BIO (01801.HK), reiterated at Overweight with target price being lifted to $...
2022/05/12 15:48
Recommend
50
Positive
104
Negative
51
SIHUAN PHARM (00460.HK) said that rumor about privatization talks, relevant valuation and privatization price was false, clarifying that the company has not negotiated with China Resources or any other institutions or organizations in respect of the matters mentioned by the news. It also made clear that it has no plan to take th...
2022/05/12 15:33
Recommend
49
Positive
94
Negative
84
SIHUAN PHARM (00460.HK) told Chinese media that the earlier privatization news was unfounded, clarifying that the company has not negotiated with China Resources or any other institutions or organizations in respect of the matters mentioned by the news. It also made clear that it has no plan to take the group private.Earlier new...
2022/05/12 14:31
Recommend
103
Positive
167
Negative
80
China Resources and SIHUAN PHARM (00460.HK) Chairman Che Fengsheng are in initial talks over taking the latter private, expecting the deal to be valued at almost US$3 billion, as foreign media cited people with knowledge of the matter.Favoring SIHUAN PHARM's rapid growth in medical aesthetics business, China Resources is pla...
2022/04/04 15:17
Recommend
142
Positive
303
Negative
141
CSPC PHARMA (01093.HK) expanded by 5% to post at $9.29 after the company obtained approval from the Chinese government to conduct clinical trials on its self-developed mRNA COVID-19 vaccine in China. Relevant vaccine-related stocks were likewise brisk on the back of the growing expectation that the authorization of vaccine usage...
2022/03/29 12:26
Recommend
70
Positive
156
Negative
81
SIHUAN PHARM (00460.HK) announced annual result ended December 2021. The net profit amounted to RMB417 million, down 12% YoY. EPS was RMB4.42 fen. A total dividend of RMB10.8 fen was declared, including a final dividend of RMB1.3 fen and a special dividend of RMB9.5 fen.~AAStocks Financial NewsWeb Site: www.aastocks.com
 
SITEMAP
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
You expressly agree that the use of this app/website is at your sole risk.

AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd, Nasdaq, Inc., their respective holding companies and/or any subsidiaries of such holding companies, their Sources and/or other third party data provider(s) endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co.Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) make any express or implied offers, representations or warranties (including, without limitation, any warranty or merchantability or fitness for a particular purpose or use) regarding the Information.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) will be liable to any Subscriber or any other party for any interruption, inaccuracy, error, or omission, regardless of cause, in the Information or for any damages (whether direct or indirect, consequential, punitive, or exemplary) resulting from its use by any party.

AASTOCKS.com Limited shall not be liable for any failure or delay in performance of its obligations under this Disclaimer because of circumstances beyond its reasonable control, including but without limitation, acts of God, typhoons, rainstorms, other natural disasters, government restrictions, strikes, wars, virus outbreak, network failures or telecommunications failures.

Morningstar Disclaimer: Copyright © 2020 Morningstar, Inc. All Rights Reserved. The information, data, analyses and opinions ("Information") contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may not be copied or redistributed except as specifically authorised; (3) do not constitute investment advice; (4) are provided solely for informational purposes; and (5) are not warranted to be complete, accurate or timely. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

The information and contents contained in this app/website are based on the analyses and interpretations of publicly available information obtained from sources believed to be reliable. Such analyses and information have not been independently verified and AASTOCKS.com Limited makes no guarantees to their accuracy, completeness, timeliness or correctness.

The information, financial market data, quotes, charts, statistics, exchange rate, news, research, analysis, buy and sell ratings, Education Center and other information on this app/website should be used as references only at your own discretion. Prior to the execution of a security trade based upon the Information, you are advised to consult independent professional advice to verify pricing information or to obtain more detailed market information. AASTOCKS.com Limited is not soliciting any subscriber or app/website visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this app/website are taken at your own risk for your own account.

AASTOCKS.com Limited provides the information and services on an "AS IS" basis. The information and contents on this app/website are subject to change without notice. AASTOCKS.com Limited reserves the right, in its sole discretion but without any obligation, to make improvements to, or correct any error or omissions in any portion of this app/website at any time.

The subscriber or app/website visitor agrees not to reproduce, retransmit, disseminate, distribute, broadcast, publish, circulate, sell or commercially exploit the information and contents on this app/website in any manner without the express written consent of AASTOCKS.com Limited.

Investment involves risk. You may make use of the Education Center of this website for academic reference purposes at your own discretion. AASTOCKS.com Limited cannot and does not give any assurance that the present or future buy/sell commentaries and signals on this app/website will be profitable. AASTOCKS.com Limited cannot guarantee, and the subscriber or app/website visitor should not assume, that the future performance will equal past performance.

AASTOCKS.com Limited may point to other sites that may be of interest to the subscriber or app/website visitor but for which AASTOCKS.com Limited has no responsibility and only provides this as a service to the subscriber or app/website visitor.

AASTOCKS.com Limited does not represent or endorse the accuracy or reliability of any information, advertisements or contents contained on, distributed through, or linked, downloaded or accessed from any of the services on this app/website. AASTOCKS.com Limited cannot and does not guarantee the quality or reliability of any products or information purchased or obtained by you as a result of an advertisement or any other information displayed on this app/website.

AATV is a video platform owned by AASTOCKS.com Limited.

You acknowledge that: (i) AATV is provided for information purposes only and, in particular, is not intended for trading purposes; (ii) AATV does not and none of the information contained in its program constitutes a solicitation, offer, opinion, or recommendation by us to buy or sell any security, or to provide legal, tax, accounting, or investment advice or services whether or not regarding the profitability or suitability of any security or investment; and (iii) AATV is not intended for use by, or distribution to, any person or entity in any jurisdiction or country where such use or distribution would be contrary to law or regulation.

The financial analysis or opinion expressed in the AATV programs is for reference and discussion only, and does not represent AASTOCKS.com Limited. Investors must make their own investment decisions based on their own investment objectives and financial situation. AASTOCKS.com Limited shall not, directly or indirectly, be liable, in any way, to you or any other person for any: (i) inaccuracies or errors in or omissions from AATV including, but not limited to, quotes and financial data; (ii) delays, errors, or interruptions in the transmission or delivery of AATV; or (iii) loss or damage arising therefrom or occasioned thereby, or by any reason of nonperformance.

AASTOCKS.com Limited reserves the right to change this Disclaimer at any time by posting changes online at this app/website. You are responsible for reviewing regularly information posted therein to obtain timely notice of such changes. Your continued use of this app / website after changes are posted constitutes your acceptance of this Agreement as modified by the posted changes.

The disclaimer herein shall be governed by the law of the Hong Kong Special Administrative Region of the People's Republic of China ("Hong Kong") and you agree to submit to the exclusive jurisdiction of the Hong Kong courts.

In the event of any discrepancy between the Chinese and English versions, the English version shall prevail.

Last updated on 11 March 2020.